Welcome to LookChem.com Sign In|Join Free

CAS

  • or

31523-05-4

Post Buying Request

31523-05-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

31523-05-4 Usage

General Description

5-amino-3,3-dimethylindolin-2-one is a chemical compound with a molecular formula of C11H14N2O. It is an indolinone derivative with a substituted amino group and two methyl groups attached to the indolinone ring. 5-amino-3,3-dimethylindolin-2-one has potential applications in the pharmaceutical industry due to its structural properties and potential biological activities. Its unique structure makes it a versatile building block for the synthesis of various organic compounds and potential drug candidates. However, further research and studies are needed to fully understand its potential applications and biological activities.

Check Digit Verification of cas no

The CAS Registry Mumber 31523-05-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,1,5,2 and 3 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 31523-05:
(7*3)+(6*1)+(5*5)+(4*2)+(3*3)+(2*0)+(1*5)=74
74 % 10 = 4
So 31523-05-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H12N2O/c1-10(2)7-5-6(11)3-4-8(7)12-9(10)13/h3-5H,11H2,1-2H3,(H,12,13)

31523-05-4Relevant articles and documents

Kinase inhibitors (by machine translation)

-

Paragraph 0492; 0495, (2020/12/31)

The present invention relates to certain 4 - (substituted anilino) -2 - (substituted piperi -1 -yl) pyrimidine -5 - carboxamide compounds useful for the treatment or prevention of diseases or medical conditions mediated by signal transduction of CaMMK1 isotype. For example, such compounds and salts thereof may be used to treat or prevent a variety of different cancers. Diseases (including 2 diabetes) and/or immune-mediated diseases. (by machine translation)

Pentacyclic kinase inhibitors

-

Page/Page column 44, (2010/11/25)

The invention provides novel kinase inhibitors that are useful as therapeutic agents for example in the treatment malignancies where the compounds have the general formula I wherein A, X, Y, Z, Ra, Rb, Rc, R1, R2, R3 and m are defined herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 31523-05-4